Overall N = 300 | Investigational Arm N = 149 | Control Arm N = 151 | Adeno-carcinoma N = 189 | Squamous Cell Carcinoma N = 111 | |
---|---|---|---|---|---|
Overall (N) | 8.7% (26b) | 9.4% (14a) | 7.9% (12) | 11.1% (21a) | 4.5% (5) |
Preoperative (N = 300) | 6.7% (20b) | 8.0% (12a) | 5.3% (8) | 9% (17a) | 2.7% (3) |
Ind-CT | 1.3% (4) | 1.3% (2) | 1.3% (2) | 1.6% (3) | 0.9% (1) |
RCT | 5.6% (16b) | 7.1% (10a) | 4.1% (6) | 7.7% (14a) | 1.9% (2) |
Postoperative (N = 259) | 3.1% (8) | 3.1% (4) | 3.1% (4) | 3.5% (6) | 2.3% (2) |